2014 Report Reveals Opportunities for Stem Cell Product Dominance
News Aug 21, 2014
Launched June 2014, the market intelligence report “Stem Cell Research Products – Opportunities, Tools, and Technologies” supplies research supply companies with the real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition.
In 2006 there were only 17 companies selling stem cell specific products to scientists. Today, there are now over one hundred companies that offer targeted products for stem cell research, a growth of over 500% in only eight years. The trend is continuing – there are over one million stem cell researchers worldwide and the number of companies selling stem cell products is accelerating faster than ever.
When asked about this phenomenal growth and its impact on companies selling products to stem cell scientists, BioInformant’s Head of Project Management, Lance Breastgoff, said, “In a cut-throat industry, you need to identify key opportunities before the competition. Because of the rapidly changing nature of this market, you need to know what is trending now.”
With such intense competition, companies marketing to the stem cell researchers need every advantage to stay ahead and the report, “Stem Cell Research Products – Opportunities, Tools, and Technologies” provides the edge to do this.
This 2014 report is unique in the breadth and depth of input sources that were used to identify industry trends, including: Stem Cell Patent Databases, Stem Cell Publication Databases, Stem Cell Grant Funding Databases, Product Launch Announcements, Press Releases, International Surveys, and more.
In reference to the “Scientist Survey” contained within the report, Breastgoff said, “The report provides insights into the minds of 289 stem cell researchers worldwide, revealing their needs, technical preferences, and current purchasing decisions. You can use it to create high-demand products that will have researchers pursuing your products over the competition.”
As the global leader in stem cell industry data, BioInformant has already served most of the world’s leading research product companies, including: BD Biosciences, Corning, Sigma Aldrich, GE Biosciences, Beckman Coulter, Thermo Fischer Scientific, ATCC, Novus Biologicals, GE Biosciences, Novartis, EMD Millipore, Sanofi Aventis, Applied Stem Cell, and others.
High blood pressure, or hypertension, is suggested to be one of the leading risk factors for heart disease. The process in which high blood pressure causes heart disease is not completely understood. Now, researchers have found that high blood pressure caused by specific signalling from the brain promotes heart disease by altering stem cells with the bone marrow.READ MORE
13th Annual Conference on Stem Cell & Regenerative Medicine
Mar 07 - Mar 09, 2019